Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bio-Techne Corporation before investing.

In this article, we go over a few key elements for understanding Bio-Techne Corporation’s stock price such as:

• Bio-Techne Corporation’s current stock price and volume
• Why Bio-Techne Corporation’s stock price changed recently
• Upgrades and downgrades for TECH from analysts
• TECH’s stock price momentum as measured by its relative strength

About Bio-Techne Corporation (TECH)

Before we jump into Bio-Techne Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Want to learn more about Bio-Techne Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bio-Techne Corporation.

Bio-Techne Corporation’s Stock Price as of Market Close

As of May 13, 2026, 9:56 AM, CST, Bio-Techne Corporation’s stock price was $45.875.

Bio-Techne Corporation is down 3.26% from its previous closing price of $47.420.

During the last market session, Bio-Techne Corporation’s stock traded between $45.730 and $47.130. Currently, there are approximately 156.33 million shares outstanding for Bio-Techne Corporation.

Bio-Techne Corporation’s price-earnings (P/E) ratio is currently at 68.2, which is high compared to the Life Sciences Tools & Services industry median of 32.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Bio-Techne Corporation Stock Price History

Bio-Techne Corporation’s (TECH) price is currently down 17.07% so far this month.

During the month of May, Bio-Techne Corporation’s stock price has reached a high of $57.010 and a low of $45.115.

Over the last year, Bio-Techne Corporation has hit prices as high as $72.160 and as low as $45.115. Year to date, Bio-Techne Corporation’s stock is down 21.99%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bio-Techne Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 12, 2026, there was 1 analyst who downgraded Bio-Techne Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bio-Techne Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bio-Techne Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Bio-Techne Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bio-Techne Corporation (TECH) by visiting AAII Stock Evaluator.

Relative Price Strength of Bio-Techne Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 12, 2026, Bio-Techne Corporation has a weighted four-quarter relative price strength of -11.90%, which translates to a Momentum Score of 23 and is considered to be Weak.

Want to learn more about how Bio-Techne Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bio-Techne Corporation Stock Price: Bottom Line

As of May 13, 2026, Bio-Techne Corporation’s stock price is $45.875, which is down 3.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bio-Techne Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.